Table 5.
Groups | Traits 1 | |||
---|---|---|---|---|
TWBC (10 3/mL) | H/L Ratio | LCV (%) | ||
PR effect | −PR | 44.09 b | 0.43 a | 105 b |
+PR | 48.60 a | 0.38 b | 115 a | |
n | 20 | 20 | 20 | |
SEM | 0.455 | 0.005 | 0.4 | |
p-value | <0.001 | <0.001 | <0.001 | |
BP effect | −BP | 45.76 | 0.42 a | 106 b |
+BP | 46.93 | 0.39 b | 114 a | |
n | 20 | 20 | 20 | |
SEM | 0.455 | 0.005 | 0.4 | |
p-value | 0.076 | <0.001 | <0.001 | |
Interaction effect | CONT | 43.24 | 0.45 | 100 d |
PR | 48.28 | 0.39 | 113 b | |
BP | 44.94 | 0.41 | 110 c | |
PR + BP | 48.93 | 0.37 | 118 a | |
n | 10 | 10 | 10 | |
SEM | 0.644 | 0.008 | 0.5 | |
p-value | 0.422 | 0.194 | <0.001 |
Means with dis-similar superscripts (a, b, c, d) in the same column significantly differ at p < 0.05. SEM: standard error of means. n: number of observations in the treatment group. 1 Traits: TWBC, total white blood cells; H/L ratio, heterophils to lymphocytes (H/L) ratio; and LCV, leukocyte cell viability.